Novo Nordisk Faces Reputational Challenges After Significant Layoffs
SOURCENews reportView the filing ↗
What we know
Location: Bagsværd, Denmark.
Department affected: Production.
Based on news reporting.
Summary
Novo Nordisk has recently laid off approximately 2,000 employees as part of a restructuring effort aimed at streamlining operations and addressing rising costs. The layoffs, which occurred in October 2023, have raised concerns about the company's reputation and its ability to maintain employee morale. The company is facing challenges in the competitive pharmaceutical market, which has prompted these significant workforce reductions. While the layoffs are intended to improve efficiency, they have sparked discussions about the long-term impact on the company's culture and public perception.
Novo Nordisk cut 2,000 jobs affecting its Production team as of January 17, 2026.
That is roughly 4.4% of the 45,000 people Novo Nordisk employs.
LayoffTalk has tracked 28 layoff events at Novo Nordisk since October 2023, including 811 jobs documented in official WARN filings, with 27 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Novo Nordisk
Recent tracked events at this company.